(Q38021413)

27 August 2017

New therapeutic paradigm for patients with cirrhosis (English)

1 reference

27 August 2017

1

1 reference

PubMed ID

22729954

27 August 2017

Andrew Kenneth Burroughs

series ordinal

3

object named as

Andrew K Burroughs

1 reference

27 August 2017

2

Jaime Bosch

1 reference

PubMed ID

22729954

27 August 2017

language of work or name

English

0 references

publication date

1 November 2012

1 reference

27 August 2017

1 reference

27 August 2017

56

1 reference

27 August 2017

5

1 reference

27 August 2017

1983-1992

1 reference

Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis

27 August 2017

1 reference

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

21 January 2018

1 reference

Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis

21 January 2018

1 reference

Renal failure and cirrhosis: a systematic review of mortality and prognosis

21 January 2018

1 reference

Impact of obesity on treatment of chronic hepatitis C.

21 January 2018

1 reference

Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study

21 January 2018

1 reference

Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis

21 January 2018

1 reference

Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database

21 January 2018

1 reference

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

21 January 2018

1 reference

Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.

21 January 2018

1 reference

Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis

21 January 2018

1 reference

Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach

21 January 2018

1 reference

Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B.

21 January 2018

1 reference

Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease

21 January 2018

1 reference

Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.

21 January 2018

1 reference

Smoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths

21 January 2018

1 reference

Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach

21 January 2018

1 reference

Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States

21 January 2018

1 reference

Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C

21 January 2018

1 reference

Coffee Consumption and Risk of Liver Cancer: A Meta-Analysis

21 January 2018

1 reference

Increased caffeine consumption is associated with reduced hepatic fibrosis

21 January 2018

1 reference

Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension

21 January 2018

1 reference

Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial.

21 January 2018

1 reference

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension.

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

21 January 2018

1 reference

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

21 January 2018

1 reference

Boceprevir for untreated chronic HCV genotype 1 infection

21 January 2018

1 reference

Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study

21 January 2018

1 reference

Peginterferon plus ribavirin and sustained virological response in HCV-related cirrhosis: outcomes and factors predicting response

21 January 2018

1 reference

Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C.

21 January 2018

1 reference

Review article: the extra-skeletal effects of vitamin D in chronic hepatitis C infection

21 January 2018

1 reference

Primary prevention of variceal haemorrhage: a pharmacological approach

21 January 2018

1 reference

Management of varices and variceal hemorrhage in cirrhosis

21 January 2018

1 reference

The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough

21 January 2018

1 reference

Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.

21 January 2018

1 reference

Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.

21 January 2018

1 reference

Gastrointestinal bleeding: Carvedilol-the best beta-blocker for primary prophylaxis?

21 January 2018

1 reference

Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed.

21 January 2018

1 reference

How to prevent varices from bleeding: shades of grey--the case for nonselective beta blockers.

21 January 2018

1 reference

Infection, coagulation, and variceal bleeding in cirrhosis

21 January 2018

1 reference

beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.

21 January 2018

1 reference

Splanchnic sympathectomy prevents translocation and spreading of E coli but not S aureus in liver cirrhosis

21 January 2018

1 reference

Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding

21 January 2018

1 reference

Propranolol for severe hemangiomas of infancy.

21 January 2018

1 reference

Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites

21 January 2018

1 reference

Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis

21 January 2018

1 reference

The role of intestinal endotoxin in liver injury: a long and evolving history

21 January 2018

1 reference

TLR4 enhances TGF-beta signaling and hepatic fibrosis

21 January 2018

1 reference

Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver

21 January 2018

1 reference

Evidence of neutrophil functional defect despite inflammation in stable cirrhosis.

21 January 2018

1 reference

Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis.

21 January 2018

1 reference

Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis.

21 January 2018

1 reference

Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis

21 January 2018

1 reference

The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial

21 January 2018

1 reference

Rifaximin treatment in hepatic encephalopathy

21 January 2018

1 reference

Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy

21 January 2018

1 reference

Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial).

21 January 2018

1 reference

Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis

21 January 2018

1 reference

Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis

21 January 2018

1 reference

Probiotic yogurt for the treatment of minimal hepatic encephalopathy.

21 January 2018

1 reference

Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.

21 January 2018

1 reference

Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial

21 January 2018

1 reference

Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes

21 January 2018

1 reference

Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity

21 January 2018

1 reference

Hemostasis and thrombosis in patients with liver disease: the ups and downs

21 January 2018

1 reference

Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests

21 January 2018

1 reference

Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy

21 January 2018

1 reference

Thrombin generation in patients with cirrhosis: the role of platelets

21 January 2018

1 reference

Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism

21 January 2018

1 reference

Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study

21 January 2018

1 reference

Coagulation and fibrosis in chronic liver disease

21 January 2018

1 reference

Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis

21 January 2018

1 reference

Systematic review: portal vein thrombosis in cirrhosis

21 January 2018

1 reference

Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation

21 January 2018

1 reference

Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis

21 January 2018

1 reference

Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis

21 January 2018

1 reference

Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients

21 January 2018

1 reference

Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study

21 January 2018

1 reference

The association of early post-transplant glucose levels with long-term mortality.

21 January 2018

1 reference

Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites

21 January 2018

1 reference

Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective

21 January 2018

1 reference

Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease

21 January 2018

1 reference

Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy

21 January 2018

1 reference

Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: A cross-over study

21 January 2018

1 reference

Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in Cirrhosis

21 January 2018

1 reference

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

21 January 2018

1 reference

Association of caffeine intake and histological features of chronic hepatitis C

21 January 2018

1 reference

Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats

21 January 2018

1 reference

Prolonging survival in patients with cirrhosis: old drugs with new indications

21 January 2018

1 reference

7 January 2021

How should we balance individual and population benefits of statins for preventing cardiovascular disease?

1 reference

7 January 2021

Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis

1 reference

7 January 2021

Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B

1 reference

7 January 2021

Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis

1 reference

7 January 2021

Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis

1 reference

7 January 2021

Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis

1 reference

7 January 2021

Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population

1 reference

7 January 2021

Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis

1 reference

7 January 2021

Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension

1 reference

7 January 2021

Development of Ascites in Compensated Cirrhosis With Severe Portal Hypertension Treated With β-Blockers

1 reference

7 January 2021

Is hydrophobia necessary for the hepatologist prescribing nonselective beta-blockers in cirrhosis?

1 reference

7 January 2021

Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS

1 reference

7 January 2021

Management of adult patients with ascites due to cirrhosis: an update

1 reference

7 January 2021

Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis

1 reference

7 January 2021

Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia

1 reference

7 January 2021

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial

1 reference

7 January 2021

Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease

1 reference

7 January 2021

A new era for anticoagulation in atrial fibrillation

1 reference

7 January 2021

Noninvasive assessment of liver fibrosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.25915

1 reference

27 August 2017

1 reference

PubMed ID

22729954